Companies scramble to expand coronavirus vaccine supply
Pfizer-BioNTech and Moderna increased their forecast for global production during the past two weeks, citing growing experience and efficiency of manufacturing. But companies with vaccine candidates still in clinical studies have reported manufacturing challenges.